Jamp-telmisartan Tablet: Overweight & Underweight Tablets
Jamp-Telmisartan tablets in 40 mg and 80 mg strengths are being recalled across Canada because some tablets weigh more or less than they should, which is a product quality issue. This recall affects patients who have been taking this blood pressure medication. The recall is classified as Class I, meaning there is a serious potential health risk.
- Product
- Jamp-Telmisartan 40 mg & 80 mg tablet
- Reason
- Product quality
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2024-09-09
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/6a72b3f2-6754-4399-b255-fb107e48d6f7